Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Patient plan: look up a medication list

AMOXICILLIN

All products: general benefit

Other products in the same Health Canada class (J01C, J01CA) — coverage varies; not interchangeable

  • Ampicillin (Penbritin): general benefit, Not a benefit
  • Amoxicillin + clavulanic acid (Clavulin): general benefit, Not a benefit
  • Cloxacillin (Orbenin): general benefit, Not a benefit
  • Penicillin v (Nadopen-V): general benefit, Not a benefit
  • Piperacillin + tazobactam (Tazocin): not a benefit

Auro-Amoxicillin · DIN 02458594 · 50mg/mL · oral liquid

General benefitMarketed · checked 2026-09-20
StatusGeneral benefit
Special Drugs ProgramSpecial Drugs Program: Amoxicillin, ascorbic acid (Vitamin C), deferoxamine, folic acid, hydrocortisone injection, penicillin and trimethoprim/sulfamethoxazole for the treatment of thalassaemia (ontario.ca, Updated 2023-07-13 ↗) Through the Special Drugs Program, the Ministry of Health covers the full cost of certain outpatient drugs used in the treatment of specific conditions. (ontario.ca, Updated 2023-07-13 ↗) The Special Drugs Program will cover costs for the above drugs if the patient: is an Ontario resident has a valid Ontario Health Insurance (OHIP) has one of the diseases or conditions covered meets the established clinical criteria is under the care of an approved physician/designated care centre (ontario.ca, Updated 2023-07-13 ↗)
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Auro-Amoxicillin · DIN 02458594 Manufacturer: Auro Pharma Inc.; listing date 2023-11-30 Daily cost (source): $0.8100 Health Canada: Marketed since 2021-10-14 · brand AURO-AMOXICILLIN · ATC J01CA04 AMOXICILLIN · form Powder for suspension · route Oral · ingredients AMOXICILLIN (AMOXICILLIN TRIHYDRATE) 250 MG/5ML · company Auro pharma inc · schedule Prescription
Check this DIN again · Health Canada product record

Auro-Amoxicillin: Formulary list price $0.0540/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0540 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=94574 · Verify on the e-Formulary ↗ (DIN 02458594)

Source record
DIN 02458594: Auro-Amoxicillin Raw flags: sec3=Y Item: 081216037; group id 25; item number 0046; lccId None; manufacturer id AUR Source form: O/L; strength: 50mg/mL Recorded listing: General benefit Source prices (unrounded): $0.0540; ministry $0.0540 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02458594 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=94574
Interchangeable products
Amoxicillin · DIN 02352753 · $0.0540 Amoxicillin · DIN 02401541 · $0.0540 Amoxicillin (Sugar Reduced) · DIN 02352788 · $0.0540 Amoxil · DIN 02042592 · not recorded Apo-Amoxi · DIN 00628158 · $0.0540 Jamp-Amoxicillin · DIN 02535815 · $0.0540 Novamoxin · DIN 00452130 · $0.0540 Novamoxin (Sugar Reduced) · DIN 01934163 · $0.0540 Sandoz Amoxicillin · DIN 02495864 · $0.0540
Shortage status: not checked (no credentials)
Other drugs in the same formulary class (08:12:16 Penicillins) and how they are covered

Matched class: 08:12:16 Penicillins

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Some products covered without a code (check the product listing): AMOXICILLIN & CLAVULANIC ACID, AMPICILLIN, CLOXACILLIN, PENICILLIN V (POTASSIUM) 08:12:16 Penicillins

AMPICILLIN

· 4 products · Listed, not a benefit (2), General benefit (2) · strengths: 250mg, 500mg · Cap

AMOXICILLIN & CLAVULANIC ACID

· 25 products · General benefit (22), Listed, not a benefit (3) · strengths: 25mg & 6.25mg/mL, 50mg & 12.5mg/mL, 200mg & 28.5mg/5mL, 400mg & 57mg/5mL, 250mg & 125mg, 500mg & 125mg, 875mg & 125mg · O/L, Susp, Tab

CLOXACILLIN

· 8 products · Listed, not a benefit (3), General benefit (5) · strengths: 250mg, 500mg, 25mg/mL · Cap, O/L

PENICILLIN V (POTASSIUM)

· 4 products · Listed, not a benefit (2), General benefit (2) · strengths: 25mg/mL, 300mg · O/L, Tab

PIPERACILLIN SODIUM & TAZOBACTAM SODIUM

· 18 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 2g & 250mg, 3g & 375mg, 4g & 500mg · Inj Pd-2.25g Vial Pk, Inj Pd-3.375g Vial Pk, Inj Pd-4.5g Vial Pk Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 08:12:16
Full class listing Related classes: 08:12:04 Antifungals, 08:12:07 Carbapenems, 08:12:12 Erythromycins, 08:12:24 Tetracyclines, 08:12:28 Other Antibiotics, 08:14:08 Azoles Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
1 INDICATIONS Novamoxin (amoxicillin) may be indicated in the treatment of infections due to susceptible strains of the following micro-organisms: Gram-negative organisms: H. influenzae, P. mirabilis and N. gonorrhoeae. Gram-positive organisms: Streptococci (including Streptococcus faecalis and Streptococcus pneumoniae). Amoxicillin is not active against Pseudomonas aeruginosa, indole-positive Proteus species, Serratia marcescens, Klebsiella and Enterobacter species. In emergency cases, where the causative organism is not yet identified, therapy may be initiated with amoxicillin on the basis of clinical judgment while awaiting bacteriologic tests to determine its antimicrobial sensitivity. Novamoxin may be indicated as a prophylaxis against alpha-hemolytic (Viridan's group) Streptococci before dental, oral or upper respiratory tract surgery or instrumentation. It may be also indicated as a prophylaxis of bacterial endocarditis in patients with any of the following conditions: congenital cardiac malformations, rheumatic and other acquired valvular lesions, prosthetic heart valves, previous history of bacterial endocarditis, hypertrophic cardiomyopathy, surgically constr… https://pdf.hres.ca/dpd_pm/00080491.PDF PM date: February 9, 1979 Source product: NOVAMOXIN; DIN 00406716; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.